EPISODE · Apr 27, 2018 · 8 MIN
A New Startup Wants to Use Crispr to Diagnose Disease
from Science, Spoken · host WIRED
In 2011, biologists Jennifer Doudna and Emmanuelle Charpentier published a landmark paper introducing the world to Crispr. The arcane family of bacterial proteins had a talent for precisely snipping DNA, and one of them—Cas9—has since inspired a billion-dollar boom in biotech investment. Clinical trials using Cas9 clippers to fix genetic defects are just beginning, so it will be years before Crispr-based cures could potentially reach the world. Learn more about your ad choices. Visit podcastchoices.com/adchoices
What this episode covers
In 2011, biologists Jennifer Doudna and Emmanuelle Charpentier published a landmark paper introducing the world to Crispr. The arcane family of bacterial proteins had a talent for precisely snipping DNA, and one of them—Cas9—has since inspired a billion-dollar boom in biotech investment. Clinical trials using Cas9 clippers to fix genetic defects are just beginning, so it will be years before Crispr-based cures could potentially reach the world. Learn more about your ad choices. Visit podcastchoices.com/adchoices
NOW PLAYING
A New Startup Wants to Use Crispr to Diagnose Disease
No transcript for this episode yet
Similar Episodes
No similar episodes found.